Cargando…
miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8
miR-223-5p has been demonstrated to regulate the development and progression of various cancers, such as hepatocellular carcinoma, breast cancer, and gastric carcinoma. However, the role of miR-223-5p in non-small cell lung cancer (NSCLC) requires further investigation. In this study, we found that...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848460/ https://www.ncbi.nlm.nih.gov/pubmed/29615147 http://dx.doi.org/10.3727/096504018X15219188894056 |
_version_ | 1783645142075310080 |
---|---|
author | Dou, Liyan Han, Kaiyu Xiao, Mochao Lv, Fuzhen |
author_facet | Dou, Liyan Han, Kaiyu Xiao, Mochao Lv, Fuzhen |
author_sort | Dou, Liyan |
collection | PubMed |
description | miR-223-5p has been demonstrated to regulate the development and progression of various cancers, such as hepatocellular carcinoma, breast cancer, and gastric carcinoma. However, the role of miR-223-5p in non-small cell lung cancer (NSCLC) requires further investigation. In this study, we found that the expression of miR-223-5p was significantly downregulated in NSCLC tissues and cell lines. Moreover, the expression level of miR-223-5p is negatively correlated with the malignance of NSCLC. We found that overexpression of miR-223-5p remarkably suppressed the proliferation of NSCLC cells in vitro and in vivo. miR-223-5p overexpression also led to reduced migration and invasion in NSCLC cells. Mechanistically, we found that E2F8, a key transcription factor involved in many kinds of biological processes, was a direct target gene of miR-223-5p. Overexpression of miR-223-5p significantly decreased the mRNA and protein levels of E2F8 in NSCLC cells. We also showed that restoration of E2F8 rescued the proliferation, migration, and invasion of miR-223-5p-overexpressing NSCLC cells. Taken together, our findings demonstrated that miR-223-5p suppressed NSCLC progression through targeting E2F8. |
format | Online Article Text |
id | pubmed-7848460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cognizant Communication Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-78484602021-02-16 miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8 Dou, Liyan Han, Kaiyu Xiao, Mochao Lv, Fuzhen Oncol Res Article miR-223-5p has been demonstrated to regulate the development and progression of various cancers, such as hepatocellular carcinoma, breast cancer, and gastric carcinoma. However, the role of miR-223-5p in non-small cell lung cancer (NSCLC) requires further investigation. In this study, we found that the expression of miR-223-5p was significantly downregulated in NSCLC tissues and cell lines. Moreover, the expression level of miR-223-5p is negatively correlated with the malignance of NSCLC. We found that overexpression of miR-223-5p remarkably suppressed the proliferation of NSCLC cells in vitro and in vivo. miR-223-5p overexpression also led to reduced migration and invasion in NSCLC cells. Mechanistically, we found that E2F8, a key transcription factor involved in many kinds of biological processes, was a direct target gene of miR-223-5p. Overexpression of miR-223-5p significantly decreased the mRNA and protein levels of E2F8 in NSCLC cells. We also showed that restoration of E2F8 rescued the proliferation, migration, and invasion of miR-223-5p-overexpressing NSCLC cells. Taken together, our findings demonstrated that miR-223-5p suppressed NSCLC progression through targeting E2F8. Cognizant Communication Corporation 2019-02-05 /pmc/articles/PMC7848460/ /pubmed/29615147 http://dx.doi.org/10.3727/096504018X15219188894056 Text en Copyright © 2019 Cognizant, LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is licensed under a Creative Commons Attribution-NonCommercial NoDerivatives 4.0 International License. |
spellingShingle | Article Dou, Liyan Han, Kaiyu Xiao, Mochao Lv, Fuzhen miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8 |
title | miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8 |
title_full | miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8 |
title_fullStr | miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8 |
title_full_unstemmed | miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8 |
title_short | miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8 |
title_sort | mir-223-5p suppresses tumor growth and metastasis in non-small cell lung cancer by targeting e2f8 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848460/ https://www.ncbi.nlm.nih.gov/pubmed/29615147 http://dx.doi.org/10.3727/096504018X15219188894056 |
work_keys_str_mv | AT douliyan mir2235psuppressestumorgrowthandmetastasisinnonsmallcelllungcancerbytargetinge2f8 AT hankaiyu mir2235psuppressestumorgrowthandmetastasisinnonsmallcelllungcancerbytargetinge2f8 AT xiaomochao mir2235psuppressestumorgrowthandmetastasisinnonsmallcelllungcancerbytargetinge2f8 AT lvfuzhen mir2235psuppressestumorgrowthandmetastasisinnonsmallcelllungcancerbytargetinge2f8 |